BAE Systems is set to deliver the first Armored Multi-Purpose Vehicle (AMPV) to the US Army amid speculations that the programme is delayed due to the Covid-19 pandemic.
The AMPV is a US Army programme that seeks to replace the Vietnam War-era M113s with new vehicles to meet a wide range of missions in the battlefield.
BAE Systems Ground Vehicles product line AMPV programme director Bill Sheehy said: “Finalising the first AMPV for delivery marks a major milestone for the programme and the US Army.
“The AMPV is designed to meet the army’s missions for the Armored Brigade Combat Teams (ABCT), and lay the foundation for the future of the battlefield.”
The AMPV comes in five variants. The first vehicle to leave the BAE Systems production line for delivery is a mission command vehicle. This vehicle facilitates digital mission command.
The four other variants include the general-purpose vehicle, the mortar carrier, the medical evacuation vehicle and the medical treatment vehicle.
The general-purpose vehicle is designed to conduct resupply, maintenance and alternate casualty evacuation during battles while the mortar carrier will provide heavy mortar fire support to the ABCT during offensive operations.
The medical evacuation vehicle will enable immediate evacuation and begin initial treatment of the casualties.
The medical treatment vehicle is designed to serve as an operating room and offer life-sustaining care to heavily injured soldiers.
BAE Systems Combat Mission Systems vice-president and general manager Jeremy Tondreault said: “The AMPV family of vehicles provides significant power, mobility, interoperability, and survivability improvements for the ABCT.
“The AMPV has demonstrated outstanding survivability and force protection as well as flexibility and growth for the future.”
The company is expected to deliver more than 450 vehicles under the current low rate initial production contract awarded in 2018.
Last month, it was reported that the initial set of deliveries may be delayed due to certain production challenges and the Covid-19 crisis.